Laser-Induced Noninvasive Vascular Injury Models in Mice Generate Platelet- and Coagulation-Dependent Thrombi
2001; Elsevier BV; Volume: 158; Issue: 5 Linguagem: Inglês
10.1016/s0002-9440(10)64117-x
ISSN1525-2191
AutoresElliot D. Rosen, Sylvain Raymond, Amy Zollman, Francisco Noria, Mayra J. Sandoval-Cooper, Alexis Shulman, J. L. Merz, Francis Castellino,
Tópico(s)Blood Coagulation and Thrombosis Mechanisms
ResumoA minimally invasive laser-induced injury model is described to study thrombus development in mice in vivo. The protocol involves focusing the beam of an argon-ion laser through a compound microscope on the vasculature of a mouse ear that is sufficiently thin such that blood flow can be visualized by intravital microscopy. Two distinct injury models have been established. The first involves direct laser illumination with a short, high-intensity pulse. In this case, thrombus formation is inhibited by the GPIIb/IIIa antagonist, G4120. However, the anticoagulants, hirulog, PPACK, and NapC2 have minimal effect. This indicates that thrombus development induced by this model mainly involves platelet interactions. The second model involves low-intensity laser illumination of mice injected with Rose Bengal dye to induce photochemical injury in the region of laser illumination. Thrombi generated by this latter procedure have a slower development and are inhibited by both anticoagulant and anti-platelet compounds. A minimally invasive laser-induced injury model is described to study thrombus development in mice in vivo. The protocol involves focusing the beam of an argon-ion laser through a compound microscope on the vasculature of a mouse ear that is sufficiently thin such that blood flow can be visualized by intravital microscopy. Two distinct injury models have been established. The first involves direct laser illumination with a short, high-intensity pulse. In this case, thrombus formation is inhibited by the GPIIb/IIIa antagonist, G4120. However, the anticoagulants, hirulog, PPACK, and NapC2 have minimal effect. This indicates that thrombus development induced by this model mainly involves platelet interactions. The second model involves low-intensity laser illumination of mice injected with Rose Bengal dye to induce photochemical injury in the region of laser illumination. Thrombi generated by this latter procedure have a slower development and are inhibited by both anticoagulant and anti-platelet compounds. The development of transgenic and gene-targeting technologies has allowed the mouse to become a valuable genetic model to study the role of particular genes in normal and pathophysiological processes. In particular, mice have been generated with mutations and deficiencies in most components of the coagulation1Bugge TH Xiao Q Kombrinck KW Flick MJ Holmback K Danton MS Colbert MC Witte DP Fujikawa K Davie EW Degen JL Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.Proc Natl Acad Sci USA. 1996; 93: 6258-6263Crossref PubMed Scopus (293) Google Scholar, 2Carmeliet P Mackman N Moons L Luther T Gressens P Van Vlanderen I Demunck H Kasper M Breier G Evrard P Muller M Risau W Edgington T Collen D Role of tissue factor in embryonic blood vessel development.Nature. 1996; 383: 73-75Crossref PubMed Scopus (588) Google Scholar, 3Toomey JR Kratzer KE Laskey NM Stanton JT Broze GJ Targeted disruption of the murine tissue factor gene results in embryonic lethality.Blood. 1996; 88: 1583-1587PubMed Google Scholar, 4Suh TS Holmback K Jensens NJ Daugherty CC Kersten S Simon DI Potter SS Degen JL Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.Genes Dev. 1995; 9: 2020-2033Crossref PubMed Scopus (361) Google Scholar, 5Sun WY Witte DP Degen JL Colbert MC Burkart MC Holmback K Xiao Q Bugge TH Degen SJ Prothrombin deficiency results in embryonic and neonatal lethality in mice.Proc Natl Acad Sci USA. 1998; 95: 7597-7602Crossref PubMed Scopus (207) Google Scholar, 6Xue J Wu O Westfield LA Tuley EA Lu D Zhang O Sadler JE Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.Proc Natl Acad Sci USA. 1998; 95: 7603-7607Crossref PubMed Scopus (138) Google Scholar, 7Cui J O'shea KS Purkayastha A Saunders TL Ginsburg D Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V.Nature. 1996; 384: 66-68Crossref PubMed Scopus (210) Google Scholar, 8Rosen ED Chan JC Idusogie E Clotman F Vlasuk G Luther T Jalbert LR Albrecht S Zhong L Lissens A Schoonjans L Moons L Collen D Castellino FJ Carmeliet P Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.Nature. 1997; 390: 290-294Crossref PubMed Scopus (189) Google Scholar, 9Bi L Lawler AM Antonarakis SE High KA Gearhart JD Kazaian HH Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.Nat Genet. 1995; 10: 119-121Crossref PubMed Scopus (520) Google Scholar, 10Lin HF Maeda N Smithies O Straight DL Stafford DW A coagulation factor IX-deficient mouse model for human hemophilia B.Blood. 1997; 90: 3962-3966PubMed Google Scholar, 11Kundu RK Sangiorgi F Wu LY Kurachi K Anderson WF Maxson R Anderson WF Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice.Blood. 1998; 92: 168-174PubMed Google Scholar, 12Dewerchin M Liang Z Moons L Carmeliet P Castellino FJ Collen D Rosen ED Blood coagulation Factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.Thromb Haemost. 2000; 83: 185-190PubMed Google Scholar, 13Gailani D Laskey N Broze GJ A murine model of factor XI deficiency.Blood Coagul Fibrinolysis. 1997; 8: 134-144Crossref PubMed Scopus (119) Google Scholar, 14Jalbert LR Rosen ED Moons L Chan JCY Carmeliet P Collen D Castellino FJ Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.J Clin Invest. 1998; 102: 1481-1488Crossref PubMed Scopus (140) Google Scholar, 15Healy AM Rayburn HB Rosenberg RD Weiler H Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system.Proc Natl Acad Sci USA. 1995; 92: 850-854Crossref PubMed Scopus (223) Google Scholar, 16Huang ZF Higuchi D Lasky N Broze GJ Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.Blood. 1997; 90: 944-951Crossref PubMed Google Scholar, 17Denis C Methia N Frenette PS Rayburn H Ullman-Cullere M Hynes RO Wagner DD A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis.Proc Natl Acad Sci USA. 1998; 95: 9524-9529Crossref PubMed Scopus (437) Google Scholar and fibrinolytic18Carmeliet P Kieckens L Schoonjans L Ream B Van Nuffelen A Prendergast G Cole M Bronson R Collen D Mulligan RC Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.J Clin Invest. 1993; 92: 2746-2755Crossref PubMed Scopus (305) Google Scholar, 19Ploplis VA Carmeliet P Vazirzadeh S Van Vlaenderen I Moons L Plow EF Collen D Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice.Circulation. 1995; 92: 2585-2593Crossref PubMed Scopus (312) Google Scholar, 20Carmeliet P Schoonjans L Kieckens L Ream B Degen J Bronson R De Vos R van den Oord JJ Collen D Mulligan RC Physiological consequences of loss of plasminogen activator gene function in mice.Nature. 1994; 368: 419-424Crossref PubMed Scopus (915) Google Scholar systems. Such animals provide the resources to study the role of particular factors in establishing and maintaining hemostasis in vivo. Although mice provide an appropriate genetic model, their diminutive size presents a challenge in the study of hemostasis. Vascular injury models developed in larger mammals are sometimes difficult to miniaturize to apply to the mouse. Despite these difficulties, several murine vascular injury models have been developed. These include use of electrical21Carmeliet P Moons L Stassen J-M DeMol M Bouche A van den Oord JJ Kockx M Collen D Vascular wound healing and neointima formation induced by perivascular electric injury in mice.Am J Pathol. 1997; 150: 761-776PubMed Google Scholar and mechanical injuries,22Stockmans F Deckmyn H Gruwez J Vermylen J Acland R Continuous quantitative monitoring of mural, platelet-dependent, thrombus kinetics in the crushed rat femoral vein.Thromb Haemost. 1991; 65: 425-431PubMed Google Scholar, 23Stockmans F Stassen JM Vermylen J Hoylaerts MF Nystrom A A technique to investigate mural thrombus formation in small arteries and veins: I. Comparative morphometric and histological analysis.Ann Plast Surg. 1997; 38: 56-62Crossref PubMed Scopus (26) Google Scholar, 24Busuttil SJ Drumm C Ploplis VA Plow EF Endoluminal arterial injury in plasminogen-deficient mice.J Surg Res. 2000; 91: 159-164Abstract Full Text PDF PubMed Scopus (15) Google Scholar, 25Roque M Fallon JT Badimon JJ Zhang WX Taubman MB Reis ED Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils.Arterioscler Thromb Vasc Biol. 2000; 20: 335-342Crossref PubMed Scopus (191) Google Scholar FeCl3,26Kurz KD Main BW Sandusky GE Rat model of arterial thrombosis induced by ferric chloride.Thromb Res. 1990; 60: 269-280Abstract Full Text PDF PubMed Scopus (409) Google Scholar, 27Farrehi PM Ozaki CK Carmeliet P Fay WP Regulation of arterial thrombolysis by plasminogen activatorinhibitor-1 in mice.Circulation. 1998; 97: 1002-1008Crossref PubMed Scopus (195) Google Scholar laser-induced injuries,28Doutremepuich F Aguejouf O Imbault P Azougagh F Doutremepuich C Effect of the low molecular weight heparin/non steroidal anti-inflammatory drugs association on an experimental thrombosis induced by laser.Thromb Res. 1995; 77: 311-319Abstract Full Text PDF PubMed Scopus (21) Google Scholar, 29Rosenblum WI Nelson GH Pvlishock JT Laser-induced endothelial damage inhibits endothelium-dependent relaxation in the cerebral microcirculation of the mouse.Circ Res. 1987; 60: 169-176Crossref PubMed Scopus (83) Google Scholar and light-induced injuries using photoactivatable dyes.30Matsuno H Kozawa O Niwa M Ueshima S Matsuo O Collen D Uematsu T Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.Thromb Haemost. 1999; 81: 601-604PubMed Google Scholar, 31Kawasaki T Kaida T Arnout J Vermylen J Hoylaerts MF A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic.Thromb Haemost. 1999; 81: 306-311PubMed Google Scholar, 32Roesken F Ruecker M Vollmar B Boeckel N Morgenstern E Menger MD A new model for quantitative in vivo microscopic analysis of thrombus formation and vascular recanalisation: the ear of the hairless (hr/hr) mouse.Thromb Haemost. 1997; 78: 1408-1414PubMed Google Scholar, 33Roesken F Vollmar B Rucker M Seiffge D Menger MD In vivo analysis of antithrombotic effectiveness of recombinant hirudin on microvascular thrombus formation and recanalization.J Vasc Surg. 1998; 28: 498-505Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar, 34Mori M Sakata I Hirano T Obana A Nakajima S Hikida M Kumagai T Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.Jpn J Cancer Res. 2000; 91: 753-759Crossref PubMed Scopus (37) Google Scholar Most of these models involve surgical intervention that can lead to artifactual activation of the hemostatic system. The use of intravital microscopy to analyze photochemical injury to vessels of the ear of the hairless mouse addresses this concern.32Roesken F Ruecker M Vollmar B Boeckel N Morgenstern E Menger MD A new model for quantitative in vivo microscopic analysis of thrombus formation and vascular recanalisation: the ear of the hairless (hr/hr) mouse.Thromb Haemost. 1997; 78: 1408-1414PubMed Google Scholar, 33Roesken F Vollmar B Rucker M Seiffge D Menger MD In vivo analysis of antithrombotic effectiveness of recombinant hirudin on microvascular thrombus formation and recanalization.J Vasc Surg. 1998; 28: 498-505Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar This latter model has been modified and used herein to induce injury with irradiation from an argon-ion laser. Specifically, laser radiation is introduced through an optical port of the microscope and focused through the objective on the target tissue. Because the laser energy is focused at the focal plane of the microscope, the intensity of the laser beam is adjusted so that injury is only induced at a particular depth in the tissue. It is thus possible to induce injury on the luminal surface of the vessel and monitor thrombogenesis of individual thrombi by intravital microscopy. This report describes the major characteristics of this injury model. Mice for the studies included C57BL6 and Swiss Webster wild-type mice. Housing and procedures involving experimental animals were approved by Institutional Animal Cure and Use Committee of the University of Notre Dame. The experimental arrangement of components to induce and record vascular injury in real time in vivo is illustrated in Figure 1. The beam of an argon-ion laser (Innova 90-5, Coherent, CA) was introduced into an optical port of a TwinEpi attachment (Prairie Technologies, Madison, WI) to a Nikon Eclipse 600 (Nikon, Tokyo, Japan) compound microscope and directed through the objective to be focused on a sample. The laser was focused on the target with a low intensity light (using power input to the laser that does not induce lasing). An injury was induced with a short high-intensity laser burst. After laser exposure, the image of the injury generated by backlighting of the injured vessel was recorded with a charge-coupled device camera (Optronics, Goleta, CA). The recorded video image was digitized and then analyzed with Bioquant True Color Windows software (Biometrics, Nashville, TN). The design of the TwinEpi attachment also permitted illumination with a mercury lamp to generate epifluorescent images of the thrombus. Video recordings of the injury were analyzed by capturing and digitizing the recorded image at prescribed intervals (1 or 2 seconds). The captured frames were analyzed using the BioQuant True Color Windows software package (Biometrics, Nashville TN). A region of interest (ROI) was defined for the target vessel that included a portion of the target vessel that is larger than the maximum injured area. Using software tools, thresholds were set to define the thrombus in the ROI. The software was programmed to review each frame, identify the thrombus in the ROI, and to measure several different parameters including area and intensity. The increase in the integrated optical density (IOD) of the thrombus was determined by first using the BioQuant software to adjust the brightness of the video image such that the mean brightness of the pixels in the ROI was at midrange (a brightness level of 128 in a scale from 0 to 255). The background intensity was defined as the average intensity in the ROI from a captured frame corresponding to the vessel before injury. The IOD is defined as the Σ − (log[Ip/Ib] for each of the pixels in the ROI where Ip is the light intensity at the pth pixel and Ib is the background intensity. The increase of the IOD is determined by subtracting the average IOD of the first two captured frames corresponding to the vessel before injury from the IOD of subsequent frames. After the induction of injury to the vessels of the ear, the anesthetized animals were sacrificed and the animals perfused by pumping saline followed by buffered formalin into the left ventricle of the heart. Histological analyses were performed on paraffin-embedded serial sections of the injured ears. Sections at 80-μm intervals were stained with hematoxylin and eosin (H&E) for microscopic evaluation. After laser illumination, mice were perfused with saline Karnovsky’s solution (1% paraformaldahyde/2.5% glutaraldehyde, in 0.1 mol/L Na-cacodylate buffer, in which the osmolarity was adjusted with NaCl and sucrose). The injured section of ear was excised, and incubated in Karnovsky’s solution for 16 hours. The samples were rinsed twice in 0.1 mol/L Na-cacodylate buffer for 30 minutes each, and postfixed in 4% osmium tetroxide for 1 hour, and rinsed again in the same buffer. After dehydration through progressive alcohol incubations, the samples were embedded in epoxy resin. Semithin sections (0.5 μm) were stained in toluidine blue and examined with a compound microscope to identify regions of interest. Once the thrombus was identified, thin sections (90 nm) were placed onto copper grids and stained with Reynold’s lead citrate and (2%) uranyl acetate for transmission electron microscopy analysis.35Reynolds ES The use of lead citrate at high pH as an electron opaque stain in electron microscopy.J Cell Biol. 1963; 1: 208-212Crossref Scopus (17859) Google Scholar The experimental set-up illustrated in Figure 1 permits photo-induced injury at specific sites within the vasculature of the ear of a mouse. The hair on the ear of an anesthetized mouse is removed and the animal positioned in a plastic restraint on a microscope stage. The restraint is designed so one ear can be taped to a glass platform so that blood flow through the vasculature of the ear can be visualized by transillumination. Although circulation in both arteries and veins is easily visualized, this report presents a characterization of the induction of venous injuries. Although the architecture of the vasculature of the ear varies among mice, generally there are either one or two primary veins proximal to the head with a diameter of ∼200 to 350 μm. This primary vein(s) is fed by secondary veins of ∼150 to 250 μm, which in turn are fed by tertiary vessels of 100 to 200 μm. The primary, secondary, and tertiary veins are targeted in these studies because the increased pigmentation in more distal segments of the ear introduces experimental complications reducing the reproducibility of the model. Using the microscope, laser, and imaging system described in Figure 1, injury can be induced in the vessel by two distinct methods. The first involves direct laser injury of the wall of the vessel by focusing a high-energy laser pulse at the luminal surface of the vessel wall. The second involves intravenous injection of the photoactivatable dye, Rose Bengal. In this latter case, subsequent laser illumination of the target vessel results in photochemical injury at the site of illumination. Both models are minimally invasive, generate reproducible injuries, and can produce multiple injuries in a single animal. Although the two methods for inducing injuries are similar, thrombus development by the two procedures exhibits different sensitivities to anticoagulants and platelet antagonists. After positioning the anesthetized animal in a restraint on the microscope platform, the laser was focused on the target vessel. Because the laser beam focused through the microscope objective is confocal with the image generated by transmitted light, the laser energy is concentrated to a small volume around the focal plane. Initial studies established parameters to generate subocclusive thrombi. Laser illumination of larger venules (primary to tertiary venules in the ear) with the 517-nm line at 100 mW for 1 second consistently induced a subocclusive thrombus that grew in size and intensity during the course of several minutes (Figure 2A). After reaching its maximum size (∼25 to 75% the diameter of the vessel), the thrombus began to fade and then usually to embolize. Several minutes after the laser pulse, the image of the vessel stabilizes and a detectable mural thrombus remains. Laser illumination for longer times or at a higher laser intensity induces more severe injuries. For example, illumination at 100 mW for 5 seconds or longer consistently induced occlusive thrombi (data not shown). On the other hand, illumination at 20 mW for >3 minutes failed to generate detectable injury. To determine the nature of the thrombi generated in this model, the effects of coagulation inhibitors on thrombus development were examined. Anesthetized animals were administered the anti-GPIIb/IIIa inhibitor, G4120,36Lu HR Gold HK Wu Z Yasuda T Pauwels P Rapold HJ Napier M Bunting S Collen D G4120, an Arg-Gly-Asp containing pentapeptide, enhances arterial eversion graft recanalization with recombinant tissue-type plasminogen activator in dogs.Thromb Haemost. 1992; 67: 686-691PubMed Google Scholar in normal saline at a dose of 1 μg/g body weight by intravenous tail vein injection. The panels in Figure 2 illustrate the progression of two injuries induced in a C57BL6 mouse in the absence (Figure 2, top) or presence (Figure 2, bottom) of the inhibitor. In Figure 3, the areas of thrombi generated after multiple injuries as determined with the BioQuant imaging system in the presence or absence of G4120 are displayed graphically. These images (Figure 2) and analyses (Figure 3)show that thrombus development is inhibited in the presence of the antiplatelet compound. The results with anticoagulant compounds were ambiguous. Although some inhibition of thrombus development was seen with the FVII inhibitor, NapC2,37Stassens P Bergum PW Gansemans Y Jespers L Laroche Y Huang S Maki S Messens J Lauwereys M Cappello M Hotez PJ Lasters I Vlasuk GP Anticoagulant repertoire of the hookworm Ancylostoma caninum.Proc Natl Acad Sci USA. 1996; 93: 2149-2154Crossref PubMed Scopus (238) Google Scholar and the thrombin inhibitor, PPACK,38Ghebrehiwet B Randazzo BP Dunn JT Silverberg M Kaplan AP Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.J Clin Invest. 1983; 71: 1450-1456Crossref PubMed Scopus (168) Google Scholar the results were variable. Tail vein injection of 100 μl of 10 μmol/L PPACK delayed thrombus development after direct laser injury, but thrombi did form. The results were not as consistent as with the anti-GPIIb//IIIa inhibitor, G4120. Because measuring the area of the thrombus (as plotted in Figure 3) does not take into consideration the intensity or brightness of the clot, the increase of the IOD of the developing thrombus was determined. The IOD calculates the log of the ratio of the intensity at each pixel to the background intensity before injury and sums that value for each pixel in the ROI. The ROI is drawn to include a region of the target vessel that extends beyond the maximum extent of the clot. The increase in the IOD of the clot can be calculated by subtracting the value of the IOD from images of the vessel before injury from the value of the IOD after injury. Pixels in the ROI that do not change in intensity during the course of the injury (corresponding to uninjured sections of the vessel in the ROI) thus do not contribute to the increase in IOD. The increase in IOD for multiple laser-induced thrombi generated in three animals is shown in Figure 4. The general shape of the tracings for each thrombus is very similar. The IOD increases rapidly within the first 30 seconds after injury and then is maintained or increases slightly throughout the next several minutes of observation. In addition, the maximal increase in the IOD (IODmax) for each thrombus was determined. The average values of the (IODmax) for thrombi generated in each of three animals are displayed in Table 1. Interestingly, the average increase in the IOD for injuries made in each animal is very reproducible; the average (IODmax) calculated for different animals in this series of injuries was 184 ± 20%.Table 1Maximum Increase in Integrated Optical Density for Injuries Made in Multiple AnimalsMouse (no. of injuries)Average (IODmax)1 (3)184 ± 432 (4)148 ± 593 (3)222 ± 97Total (10)184 ± 37The maximum increase in IOD (IODmax) for each thrombus was determined and the mean for all injuries in each animal was calculated. Open table in a new tab The maximum increase in IOD (IODmax) for each thrombus was determined and the mean for all injuries in each animal was calculated. To analyze the nature of the laser-induced injury histologically after injury, animals were perfused by ventricular puncture first with saline, then with buffered formalin. The region of the ear surrounding the injury was excised and embedded in paraffin. The target vein was followed through serial sections enabling identification of sections of the target vessel with the induced thrombus. The panels in Figure 4 represent histological characterization of sections through a single clot induced by direct laser injury. As expected, sections preceding the injury were free of detectable clot, consistent with the local nature of the injury recorded by intravital microscopy (Figure 5A). The periphery of the thrombus includes less condensed fibrous material (Figure 5B) whereas the main body of the thrombus contains condensed material attached to the vessel wall. Histochemical analysis of other laser-induced thrombi indicates the less condensed fibrous material stains with antibodies recognizing fibrin(ogen) (data not shown). Unfortunately, the antibody recognizes both fibrinogen and fibrin, so it is not possible to tell whether fibrin generation and polymerization are required for thrombus generation. The thrombus also contains P-selectin antigen (data not shown) suggesting the presence of activated platelets within the clot. This result is consistent with the sensitivity of thrombus development to the anti-GPIIb/IIIa inhibitor G4120 (Figure 2, Figure 3). Sections stained for von Willebrand factor (data not shown), which serves as a marker for the vascular endothelium, indicate that the lumen of the vein is ringed with a layer of endothelial cells. At the resolution of the micrographs for immunohistochemical analysis, there does not seem to be major disruption of the endothelial lining of the vein. In addition, it was noted in these figures that there was no apparent damage to the tissue surrounding the target vessel. This observation supports the contention that the focusing of the laser induces injury in a small volume within the target rather than burning a vertical column through the ear. Ultrastructural analysis has been initiated to further characterize the thrombus generated by laser-induced injury. Figure 6a presents a transmission electron micrograph of a thrombus induced by direct laser injury. The figure shows polymorphonuclear cells (PMN) attached to damaged, highly vacuolated endothelium. There are numerous platelets at various stages of activation. Although the endothelium is injured, it is still attached to the substratum of the vessel wall. However, there is one site at which the subendothelial matrix is exposed and a projection from a neutrophil is shown to make contact with the subendothelial matrix (Figure 6a, insert). From this, it seems that thrombus formation does not require major denudation of the endothelium and exposure of platelets or coagulation factors to the subendothelial matrix. The micrographs also confirm the local nature of the injury. Sections ∼100-μm proximal or distal to the thrombus are free of injury. In addition, composite micrographs that allow tracing along the luminal surface indicate that while the endothelium at the site of injury is damaged, the lining on the opposite surface of the vessel appears normal (data not shown). In addition to the induction of direct laser injury with a relatively high-energy pulse for a short duration, the experimental apparatus shown in Figure 1 can also be used to induce photochemical injury. In the photochemical injury mode, mice were administered 40 μg/g body weight by tail vein injection of a 10 mg/ml solution of Rose Bengal dye dissolved in normal saline. Subsequent laser illumination induced mural clots in the target vessels near the site of illumination. Presumably, photoactivation of the Rose Bengal dye results in the generation of singlet oxygen, which induces chemical damage to the endothelium. Initial experiments were designed to determine parameters necessary to generate subocclusive thrombi in the target vessels in 8- to 12-week-old Swiss-Webster mice. Irradiation at 10 mW failed to generate thrombi in the presence or absence of Rose Bengal, even after 4 minutes of continuous illumination. Irradiation at 20 mW for 30 seconds in the presence of Rose Bengal at 40 μg/g body weight occasionally induced a faint thrombus. However, irradiation at 30 mW for 20 to 30 seconds consistently generated subocclusive thrombi in target veins. In contrast, more intense irradiation (75 mW) for 20 seconds at the same Rose Bengal concentration consistently generated occlusive clots near the site of illumination. These results indicate that the extent of thrombus development in the primary, secondary, or tertiary veins of the ear is a function of the intensity of irradiation. Similarly, the extent of injury is also affected by the duration of irradiation and concentration of Rose Bengal. Furthermore, it is possible to identify irradiation parameters to consistently generate subocclusive thrombi in the particular target vessel. In particular, subocclusive clots in secondary veins are consistently generated by 30 seconds of irradiation at 30 mW in Swiss Webster mice injected with Rose Bengal with a dose of 40 μg/g body weight. As might be expected, the parameters required to induce an injury of a particular intensity vary with the genetic background of the mouse. For instance, irradiation at 20 mW for 30 seconds induces extensive subocclusive thrombi in 129/C57BL6 mice, parameters that only induce a faint thrombus in Swiss-Webster mice. To explore the role of the coagulation system on thrombus development after photochemical injury, injuries were made in the presence or absence of the thrombin inhibitor PPACK. Anesthetized mice were administered Rose Bengal either with or without PPACK by intravenous injection into the tail vein. Figure 7 illustrates the effect of the thrombin inhibitor PPACK on photochemical injury. Figure 7, top, shows photoch
Referência(s)